Latest filing published 23 May 2019 for Thermo Fisher Scientific INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +86.5%Entry US$17.73 · Close at T+365 US$33.06
- +86.0%Entry US$17.80 · Close at T+365 US$33.10
- +86.0%Entry US$17.80 · Close at T+365 US$33.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Elaine Ullian: trading record in brief
Elaine Ullian is a declared insider at 4 companies; the most frequent names are Hologic Inc, Vertex Pharmaceuticals INC / MA and Thermo Fisher Scientific Inc. In total, 176 filings cover trades dated from 1 January 2006 to 22 May 2019.
In open-market terms, that means 6 purchases worth €218k on one side and 64 sales worth €21.2M on the other. Sales outweigh purchases by €21.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 42 share grants and 53 option exercises.
The median purchase comes to €13k. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +47.0%. This is a record of the past, not a forecast.
On 23 May 2019 came the latest disclosure, a share grant in Thermo Fisher Scientific Inc. The most recent open-market purchase was published on 9 September 2014, 4,443 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elaine Ullian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 718 shares0Common StockSEC:0001127602-19-019638:0
- 858 shares0Common StockSEC:0001127602-18-024966:0
- 1,801 shares0Common StockSEC:0001209191-18-035717:0
- 809 shares0Common StockSEC:0001127602-18-018789:0
- 9,282 shares@ US$40.504.4% of flowCommon StockSEC:0001127602-17-032192:1
- 9,282 shares@ US$18.822.0% of flowCommon StockSEC:0001127602-17-032192:0
- 3,492 shares@ US$18.820.8% of flowCommon StockSEC:0001127602-17-032192:2
- 1,451 shares0Common StockSEC:0001127602-17-025124:0
- 6,902 shares@ US$32.822.6% of flowCommon StockSEC:0001127602-17-025124:1
- 6,902 shares@ US$40.123.2% of flowCommon StockSEC:0001127602-17-025124:2
- 998 shares@ US$32.820.4% of flowCommon StockSEC:0001127602-17-025124:3
- 1,362 shares0Common StockSEC:0001127602-17-023262:0
- 8,849 shares@ US$32.823.5% of flowCommon StockSEC:0001127602-17-023262:1
- 8,849 shares@ US$45.284.8% of flowCommon StockSEC:0001127602-17-023262:2
- 1,451 shares@ US$32.820.6% of flowCommon StockSEC:0001127602-17-023262:3
- 8,938 shares@ US$32.823.6% of flowCommon StockSEC:0001127602-17-020675:1
- 8,938 shares@ US$43.994.8% of flowCommon StockSEC:0001127602-17-020675:2
- 1,362 shares@ US$32.820.5% of flowCommon StockSEC:0001127602-17-020675:3
- 1,444 shares0Common StockSEC:0001127602-17-020675:0
- 2,188 shares0Common StockSEC:0001209191-17-037914:0
- 1,024 shares0Common StockSEC:0001127602-17-018868:0
- 8,856 shares@ US$45.095.0% of flowCommon StockSEC:0001127602-17-017101:2
- 1,444 shares@ US$32.820.6% of flowCommon StockSEC:0001127602-17-017101:3
- 8,856 shares@ US$32.823.6% of flowCommon StockSEC:0001127602-17-017101:1
- 1,196 shares0Common StockSEC:0001127602-17-017101:0
25 of 173 declarations
